Collaborative Licensing in Biotechnology: A Survey of Knowledge, Experience, and Attitudes in Australia

Nicol, Dianne

doi:10.1089/blr.2010.9930

Search citation statements

Order By: Relevance

Paper Sections

Select...

Knowledge and Experience With Collaborative Licensing Models1

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2011

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

(1 citation statement)

References 16 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Recently, empirical studies focusing on collaborative licensing in medical biotechnology in Europe [30] and Australia [42] have been carried out. The results of the Australian study are discussed in detail in [43]. Here, we summarize the findings of the European study [30].…”

Section: Knowledge and Experience With Collaborative Licensing Modelsmentioning

confidence: 90%

Patent pools and clearinghouses in the life sciences

Zimmeren

Vanneste

Matthijs

et al. 2011

Trends in Biotechnology

View full text Add to dashboard Cite

The biopharmaceutical industry is slowly absorbing the idea of collaborative patent licensing models. Recently, two patent pools for developing countries have been launched: the Pool for Open Innovation against Neglected Tropical Diseases initiated by GlaxoSmithKline (GSK), which is referred to as the BIO Ventures for Global Health (BVGH) pool, and the Medicines Patent Pool (MPP) initiated by UNITAID. Various organizations have recommended using pools or clearinghouses beyond the humanitarian dimension where many patents are owned by many different actors. As a first attempt, MPEG LA, which administers patent pools in various technology fields, is now setting up a clearinghouse for patents related to molecular diagnostics. These examples as well as the results from an empirical study provide useful insights for the design and administration of future pools and clearinghouses in the life sciences.

show abstract

Section: Knowledge and Experience With Collaborative Licensing Modelsmentioning

confidence: 90%